These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23715628)

  • 1. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
    Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
    Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
    Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S
    Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 4. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.
    Ding Z; Ke R; Zhang Y; Fan Y; Fan J
    Mol Cell Endocrinol; 2019 Aug; 493():110420. PubMed ID: 31129275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.
    Liu YM; Ying SP; Huang YR; Pan Y; Chen WJ; Ni LQ; Xu JY; Shen QY; Liang Y
    World J Surg Oncol; 2016 Feb; 14(1):30. PubMed ID: 26846782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
    Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
    Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
    J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma.
    Kallel R; Belguith-Maalej S; Akdi A; Mnif M; Charfeddine I; Galofré P; Ghorbel A; Abid M; Marcos R; Ayadi H; Velázquez A; Hadj Kacem H
    Cancer Biomark; 2010-2011; 8(1):43-51. PubMed ID: 21896990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
    Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
    J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MAGE A1-6 and the clinical characteristics of papillary thyroid carcinoma.
    Lee HS; Kim SW; Hong JC; Jung SB; Jeon CH; Park JW; Park SY; Lee KD
    Anticancer Res; 2013 Apr; 33(4):1731-5. PubMed ID: 23564824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
    Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
    Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.